an overview of the current and future treatment landscape for mpns
Published 1 year ago • 104 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
1:54
current treatment landscape in classical mpns
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
1:19
the current state-of-the-art in pv and future outlooks
-
26:22
key takeaways in mpns
-
5:34
understanding how polycythemia vera (pv) may change over time
-
12:06
can patients with polycythemia vera (pv) live a normal lifespan?
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
2:14
update on the aml treatment landscape
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:55
mpns: a changing treatment landscape
-
1:30
addressing unmet needs in myelofibrosis: alleviating anemia
-
2:21
current and emerging treatment strategies for post-mpn aml
-
1:39
current landscape and future directions for lower-risk mds treatment
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
2:26
the challenges associated with transfusion dependence in patients with mf
-
2:56
novel drugs for myeloma thromboprophylaxis
-
1:02
maintenance therapy following treatment for amyloidosis
-
3:10
promising trials in polycythemia vera
-
1:51
thrombotic and bleeding complications in al amyloidosis